Oct 16, 2026
Oct 13, 2026
This week’s crypto headlines included political controversy, regulatory changes and renewed optimism around Bitcoin’s next major move. Bitcoin exchange-traded funds reversed a multibillion-dollar outflow trend, while analysts and financial institutions pointed toward higher price targets and stronger investor demand. Meanwhile,…
Oct 04, 2026
Agomab Therapeutics NV (NASDAQ:AGMB) reported results from the 48-week open-label extension portion of its Phase 2a STENOVA trial of ontunisertib for fibrostenotic Crohn’s disease. • AgomAb Therapeutics stock is showing notable weakness. Why is AGMB stock dropping? The data demonstrated…
Oct 01, 2026
FactSet Research Systems Inc. (NYSE:FDS) stock reversed early losses Wednesday after falling more than 2% in premarket trading. Investors weighed weaker-than-expected fiscal 2027 guidance against better-than-expected fiscal 2026 fourth-quarter results. FactSet reported adjusted earnings of $4.52 per share, beating the…
Sep 30, 2026
This week was a rollercoaster ride for the cryptocurrency market. Bitcoin (CRYPTO: BTC) surged to a multi-month high, Ethereum (CRYPTO: ETH) is evolving beyond a blockchain and the crypto market rallied despite legislative setbacks. Here’s a quick recap of the…
Sep 27, 2026
